221 related articles for article (PubMed ID: 20513063)
1. Prophylactic implantation of cardioverter defibrillators in idiopathic nonischemic cardiomyopathy for the primary prevention of death: a narrative review.
Cevik C; Nugent K; Perez-Verdia A; Fish RD
Clin Cardiol; 2010 May; 33(5):254-60. PubMed ID: 20513063
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
Akel T; Lafferty J
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
[TBL] [Abstract][Full Text] [Related]
3. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Stavrakis S; Asad Z; Reynolds D
J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
[TBL] [Abstract][Full Text] [Related]
5. Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Luni FK; Singh H; Khan AR; Malik SA; Khawaja O; Riaz H; Lee W; Kabour A; Richards M; Aasbo J
J Cardiovasc Electrophysiol; 2017 May; 28(5):538-543. PubMed ID: 28370885
[TBL] [Abstract][Full Text] [Related]
6. Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy.
Cavalcanti R; Aboul-Hosn N; Morales G; Abdel-Latif A
Angiology; 2018 Apr; 69(4):297-302. PubMed ID: 28554215
[TBL] [Abstract][Full Text] [Related]
7. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.
Al-Khatib SM; Fonarow GC; Joglar JA; Inoue LYT; Mark DB; Lee KL; Kadish A; Bardy G; Sanders GD
JAMA Cardiol; 2017 Jun; 2(6):685-688. PubMed ID: 28355432
[TBL] [Abstract][Full Text] [Related]
8. Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis.
Kolodziejczak M; Andreotti F; Kowalewski M; Buffon A; Ciccone MM; Parati G; Scicchitano P; Uminska JM; De Servi S; Bliden KP; Kubica J; Bortone A; Crea F; Gurbel P; Navarese EP
Ann Intern Med; 2017 Jul; 167(2):103-111. PubMed ID: 28632280
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Anantha Narayanan M; Vakil K; Reddy YN; Baskaran J; Deshmukh A; Benditt DG; Adabag S
JACC Clin Electrophysiol; 2017 Sep; 3(9):962-970. PubMed ID: 29759721
[TBL] [Abstract][Full Text] [Related]
10. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.
Desai AS; Fang JC; Maisel WH; Baughman KL
JAMA; 2004 Dec; 292(23):2874-9. PubMed ID: 15598919
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials.
Romero J; Díaz JC; Grushko M; Quispe R; Briceno D; Avendano R; Golive A; Pina I; Natale A; Garcia MJ; Jorde UP; Di Biase L
Europace; 2018 Sep; 20(FI2):f211-f216. PubMed ID: 29161424
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis.
Siddiqui WJ; Aggarwal S; Rafique M; Singh S; Kutalek S; Eisen HJ
Heart Fail Rev; 2018 Mar; 23(2):181-190. PubMed ID: 29380177
[TBL] [Abstract][Full Text] [Related]
13. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
14. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study.
Bauer A; Klemm M; Rizas KD; Hamm W; von Stülpnagel L; Dommasch M; Steger A; Lubinski A; Flevari P; Harden M; Friede T; Kääb S; Merkely B; Sticherling C; Willems R; Huikuri H; Malik M; Schmidt G; Zabel M;
Lancet; 2019 Oct; 394(10206):1344-1351. PubMed ID: 31488371
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
[TBL] [Abstract][Full Text] [Related]
16. Implantable Cardioverter-Defibrillators in Trials of Drug Therapy for Heart Failure: A Systematic Review and Meta-Analysis.
Gama F; Ferreira J; Carmo J; Costa FM; Carvalho S; Carmo P; Cavaco D; Morgado FB; Adragão P; Mendes M
J Am Heart Assoc; 2020 Apr; 9(8):e015177. PubMed ID: 32290732
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy.
Middour TG; Rosenthal TM; Abi-Samra FM; Bernard ML; Khatib S; Polin GM; Rogers PA; Bober RM; Morin DP
J Cardiovasc Electrophysiol; 2020 May; 31(5):1137-1146. PubMed ID: 32064730
[TBL] [Abstract][Full Text] [Related]
18. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.
Beggs SAS; Jhund PS; Jackson CE; McMurray JJV; Gardner RS
Heart; 2018 Jan; 104(2):144-150. PubMed ID: 28986406
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833
[TBL] [Abstract][Full Text] [Related]
20. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
